Back to List View Graph View

Insulin Therapy

Insulin therapy is a hormone-replacement treatment in which exogenous insulin is administered to lower and stabilize blood glucose in people whose endogenous insulin secretion or action is insufficient.

Where the papers sit

8 papers from the last 6 months study Insulin Therapy directly · updated from PubMed 16 Nov 2026

Those 8 are all about one subject.

  • Insulin and Diabetes Biology

    Insulin research here spans delivery systems, secretion, glucose regulation, diabetes risk and therapeutic protein quality. Human studies emphasize early insulin-secretory defects, postprandial metabolic heterogeneity and polygenic susceptibility to type 2 diabetes. Clinical analyses also track alpelisib-induced hyperglycemia and the budget impact of advanced delivery for type 1 diabetes. Mechanistic work links vagal nitric oxide signaling to insulin release and insulin exposure to IL7R+ memory phenotypes in PD1+ T cells, leaving the cluster broad rather than directional.

    8 papers

Papers

The 8 papers from the last 6 months that study Insulin Therapy directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Insulin and Diabetes Biology (8)
  1. Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 Diabetes. Diabetes technology & therapeutics · 1 Jul 2026 PMID 42381171
  2. Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation. The AAPS journal · 29 Jun 2026 PMID 42373916
  3. Global and Partitioned Polygenic Risk Scores: Associations With Pathophysiology and Incidence of Type 2 Diabetes in People With Prediabetes. Diabetes · 22 Jun 2026 PMID 42330299
  4. Vagal activation inhibits insulin release through neuronal nitric oxide synthase in obese male mice. Science signaling · 26 May 2026 PMID 42189938
  5. Insulin enables acquisition of the IL7R+ memory phenotype in PD1+ T cells in RA tissues. Cell death & disease · 25 May 2026 PMID 42185247
  6. The 1-hour plasma glucose as a specific marker for early-phase insulin secretory defects in young adults with obesity. Diabetes research and clinical practice · 25 May 2026 PMID 42184890
  7. Heterogeneity in postprandial glucose-insulin and triacylglycerol dynamics and associations with plasma metabolome and body composition in obesity. American journal of physiology. Endocrinology and metabolism · 21 May 2026 PMID 42166654
  8. Assessment of alpelisib-induced hyperglycemia in a real-world setting: A nationwide claims data analysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 20 May 2026 PMID 42159385

By study type

Clinical trials (1)
  1. Global and Partitioned Polygenic Risk Scores: Associations With Pathophysiology and Incidence of Type 2 Diabetes in People With Prediabetes. Diabetes · 22 Jun 2026 PMID 42330299
Human data, design not indexed (4)
  1. Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 Diabetes. Diabetes technology & therapeutics · 1 Jul 2026 PMID 42381171
  2. Insulin enables acquisition of the IL7R+ memory phenotype in PD1+ T cells in RA tissues. Cell death & disease · 25 May 2026 PMID 42185247
  3. The 1-hour plasma glucose as a specific marker for early-phase insulin secretory defects in young adults with obesity. Diabetes research and clinical practice · 25 May 2026 PMID 42184890
  4. Heterogeneity in postprandial glucose-insulin and triacylglycerol dynamics and associations with plasma metabolome and body composition in obesity. American journal of physiology. Endocrinology and metabolism · 21 May 2026 PMID 42166654
Preclinical: animal, cell and lab studies (2)
  1. Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation. The AAPS journal · 29 Jun 2026 PMID 42373916
  2. Vagal activation inhibits insulin release through neuronal nitric oxide synthase in obese male mice. Science signaling · 26 May 2026 PMID 42189938
Unclassified: not yet indexed with MeSH (1)
  1. Assessment of alpelisib-induced hyperglycemia in a real-world setting: A nationwide claims data analysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 20 May 2026 PMID 42159385